Lysine Biotech Logo

LYSINE BIOTECH PRIVATE LIMITED
 A Revolutionary CAR T-Cell Treatment with Global Potential
 CIN:U74999TN2018PTC122879,
 

Vision

Our vision is to develop the best, affordable life saving medicine for low income countries to treat human diseases

Mission

Our mission is to discover life saving technologies to improve and extend patients lives through innovation

Lysine Biotech's focus areas of CAR T cells therapy

To make a new approach to provide affordable, safe, and effective CAR T cells therapy, thus fostering cheaper cost.

Learn More About Products R&D Pipline

Our Features

1.Long non coding reading frames endless RNA (lncrfeRNA)

Role of thymine in protein coding frames of mRNA sequences” published in the journal" Bioinformation. 2008. 2, 304-307. doi: 10.6026/97320630002304

— a new class of programmable medicines capable of expressing chimeric antigen receptors (CARs)

Learn More About Research and Development
Lysine Biotech